Home/Filings/4/0000895345-24-000470
4//SEC Filing

Davis Aaron I. 4

Accession 0000895345-24-000470

CIK 0001819133other

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 9:31 PM ET

Size

11.3 KB

Accession

0000895345-24-000470

Insider Transaction Report

Form 4
Period: 2024-10-21
Davis Aaron I.
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2024-10-22$6.78/sh250,000$1,695,0007,323,642 total
  • Sale

    Common Stock

    2024-10-21$7.05/sh625,000$4,406,2507,573,642 total
Holdings
  • Common Stock

    (indirect: See footnote)
    108,793
  • Common Stock

    (indirect: See footnote)
    6,988,450
Transactions
  • Sale

    Common Stock

    2024-10-21$7.05/sh625,000$4,406,2507,573,642 total
  • Sale

    Common Stock

    2024-10-22$6.78/sh250,000$1,695,0007,323,642 total
Holdings
  • Common Stock

    (indirect: See footnote)
    6,988,450
  • Common Stock

    (indirect: See footnote)
    108,793
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0018 to $7.2372, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]These securities are held indirectly by Boxer Capital Management, LLC ("BCM") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.7100 to $6.9050, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. BCM disclaims beneficial ownership of these securities.
  • [F5]These securities are owned directly by BCTG Holdings, LLC ("BCTG"). MVA Investors is a member of BCTG. Mr. Davis is a member of the investment committee of BCTG. Mr. Davis disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. BCM disclaims beneficial ownership of these securities.

Documents

1 file

Issuer

Tango Therapeutics, Inc.

CIK 0001819133

Entity typeother

Related Parties

1
  • filerCIK 0001465914

Filing Metadata

Form type
4
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 9:31 PM ET
Size
11.3 KB